Association of human platelet alloantigen 1 through 5 polymorphisms with ischemic stroke

Cerebrovascular Diseases

Volumn 25, Issue 1-2, 2008, Pages 81-86

  Saidi, Sarra ^a   Mahjoub, Touhami ^a   Slamia, Lamia B ^b   Ammou, Sofyan B ^b   Al Subaie, Abeer M ^c   Almawi, Wassim Y ^c  

^a UNIVERSITY OF MONASTIR   (Tunisia)

^b SAHLOUL UNIVERSITY HOSPITAL   (Tunisia)

^c ARABIAN GULF UNIVERSITY   (Bahrain)

Author keywords

Gene polymorphisms; Human platelet alloantigens; Polymerase chain reaction; Stroke

Indexed keywords

ALLOANTIGEN; HUMAN PLATELET ALLOANTIGEN 1; HUMAN PLATELET ALLOANTIGEN 2; HUMAN PLATELET ALLOANTIGEN 3; HUMAN PLATELET ALLOANTIGEN 4; HUMAN PLATELET ALLOANTIGEN 5; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RISK FACTOR;

AGED; ANTIGENS, HUMAN PLATELET; BRAIN ISCHEMIA; CASE-CONTROL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; PLATELET MEMBRANE GLYCOPROTEINS; POLYMORPHISM, GENETIC; RECURRENCE; STROKE;

EID: 39549098647     PISSN: 10159770     EISSN: None     Source Type: Journal    
DOI: 10.1159/000111995     Document Type: Article

References (38)

1. Weyrich AS, Zimmerman GA: Platelets: signaling cells in the immune continuum. Trends Immunol 2004;25:489-495.
2. Htun P, Fateh-Moghadam S, Tomandl B, Handschu R, Klinger K, Stellos K, Garlichs C, Daniel W, Gawaz M: Course of platelet activation and platelet-leukocyte interaction in cerebrovascular ischemia. Stroke 2006;37:2283-2287.
3. Sharp DS, Ben-Shlomo Y, Beswick AD, Andrew ME, Elwood PC: Platelet aggregation in whole blood is a paradoxical predictor of ischaemic stroke: Caerphilly Prospective Study revisited. Platelets 2005;16:320-328.
4. Santoso S: Clinical impact of platelet glycoprotein polymorphism. Vox Sang 2000;78:121-124.
5. Calvete JJ: Platelet integrin GPIIb/IIIa: structure-function correlations. An update and lessons from other integrins. Proc Soc Exp Biol Med 1999;222:29-38.
6. Deckmyn H, Ulrichts H, Van De Walle G, Vanhoorelbeke K: Platelet antigens and their function. Vox Sang 2004;87(suppl 2):105-111.
7. Santoso S: Human platelet alloantigens. Transfus Apher Sci 2003;28:227-236.
8. Chen F, Jian Z, Xie Q, Pu X, Xiao B, Han L: Polymorphism of human platelet alloantigen in Chinese patients with acute myocardial infarction and acute ischemic stroke. Chin Med J 2000;113:702-705.
9. Bray PF: Platelet glycoprotein polymorphisms as risk factors for thrombosis. Curr Opin Hematol 2000;7:284-289.
10. Kunicki TJ: The influence of platelet collagen receptor polymorphisms in hemostasis and thrombotic disease. Arterioscler Thromb Vasc Biol 2002;22:14-20.
11. Ulrichts H, Vanhoorelbeke K, Cauwenberghs S, Vauterin S, Kroll H, Santoso S, Deckmyn H: von Willebrand Factor but not α-thrombin binding to platelet glycoprotein Ibα is influenced by the HPA-2 polymorphism. Arterioscler Thromb Vasc Biol 2003;23:1302-1307.
12. Kuijpers RWAM, Faber NM, Cuypers HTM, Ouwehand WH, von dem Borne AEGK: The N-terminal globular domain of the human platelet glycoprotein Iba has a methionine 145/threonine 145 amino acid polymorphism which is associated with the HPA-2 (Ko) alloantigens. J Clin Invest 1992;89:381-384.
13. 2 integrin) allele frequencies in three North American populations reveals genetic association between nucleotide 807C/T and amino acid 505 Glu/Lys (HPA-5) dimorphisms. Thromb Haemost 1998;80:449-456.
14. Halle L, Bigot A, Mulen-Imandy G, M'Bayo K, Jaeger G, Anani L, Martageix C, Bianchi F, Julien E, Kaplan C: HPA polymorphism in sub-Saharan African populations: Beninese, Cameroonians, Congolese, and Pygmies. Tissue Antigens 2005;65:295-298.
15. Yan L, Zhu F, He J, Sandler SG: Human platelet alloantigen systems in three Chinese ethnic populations. Immunohematol 2006;22:6-10.
16. Seo DH, Park SS, Kim DW, Furihata K, Ueno I, Han KS: Gene frequencies of eight human platelet-specific antigens in Koreans. Transfus Med 1998;8:129-132.
17. Chang YW, Mytilineos J, Opelz G, Hawkins BR: Distribution of human platelet antigens in a Chinese population. Tissue Antigens 1998;51:391-393.
18. Jones DC, Bunce M, Fuggle SV, Young NT, Marshall SE: Human platelet alloantigens (HPAs): PCR-SSP genotyping of a UK population for 15 HPA alleles. Eur J Immunogenet 2003;30:415-419.
19. Ferrer G, Muniz-Diaz E, Aluja MP, Arilla M, Martinez C, Nogues R, Servin A, Baali A: Analysis of human platelet antigen systems in a Moroccan Berber population. Transfus Med 2002;12:49-54.
20. Kluter H: Rapid typing for human platelet antigens systems -1, -2, -3 and -5 by PCR amplification sequence-specific primers. Vox Sang 1996;71:121-123.
21. Hurd CM, Cavanagh G, Schuh A, Ouwehand WH, Metcalfe P: Genotyping for platelet-specific antigens: techniques for the detection of single nucleotide polymorphisms. Vox Sang 2002;83:1-12.
22. Metcalfe P, Cavanagh G, Hurd C, Ouwehand WH: HPA genotyping by PCR-SSP: report of 4 exercises. Vox Sang 1999;77:40-43.
23. Cavanagh G, Dunn AN, Chapman CE, Metcalfe P: HPA genotyping by PCR sequence-specific priming (PCR-SSP): a streamlined method for rapid routine investigations. Transfus Med 1997;7:41-45.
24. Streifler JY, Rosenberg N, Chetrit A, Eskaraev R, Sela BA, Dardik R, Zivelin A, Ravid B, Davidson J, Seligsohn U, Inbal A: Cerebrovascular events in patients with significant stenosis of the carotid artery are associated with hyperhomocysteinemia and platelet antigen-1 (Leu33Pro) polymorphism. Stroke 2001;32:2753-2758.
25. Carter AM, Catto AJ, Bamford JM, Grant PJ: Association of the platelet glycoprotein IIb HPA-3 polymorphism with survival after acute ischemic stroke. Stroke 1999;30:2606-2611.
26. Baker RI, Eikelboom J, Lofthouse E, Staples N, Afshar-Kharghan V, Lopez JA, Shen Y, Berndt MC, Hankey G: Platelet glycoprotein Ibα Kozak polymorphism is associated with an increased risk of ischemic stroke. Blood 2001;98:36-40.
27. Carlsson LE, Greinacher A, Spitzer C, Walther R, Kessler C: Polymorphisms of the human platelet antigens HPA-1, HPA-2, HPA-3, and HPA-5 on the platelet receptors for fibrinogen (GPIIb/IIIa), von Willebrand factor (GPIb/IX), and collagen (GPIa/IIa) are not correlated with an increased risk for stroke. Stroke 1997;28:1392-1395.
28. Meiklejohn DJ, Vickers MA, Morrison ER, Dijkhuisen R, Moore I, Urbaniak SJ, Greaves M: In vivo platelet activation in atherothrombotic stroke is not determined by polymorphisms of human platelet glycoprotein IIIa or Ib. Br J Haematol 2001;112:621-631.
29. Wagner KR, Giles WH, Johnson CJ, Ou CY, Bray PF, Goldschmidt-Clermont PJ, Corft JB, Brown VK, Stern BJ, Feeser BR, et al: Platelet glycoprotein receptor IIIa polymorphism P1A2 and ischemic stroke risk: the Stroke Prevention in Young Women Study. Stroke 1998;29:581-585.
30. Iniesta JA, Gonzalez-Conejero R, Piqueras C, Vicente V, Corral J: Platelet GP IIIa polymorphism HPA-1 (PlA) protects against subarachnoid hemorrhage. Stroke 2004;35:2282-2286.
31. Kekomaki S, Hamalainen L, Kauppinen Makelin R, Palomaki H, Kaste M, Kontula K: Genetic polymorphism of platelet glycoprotein IIIa in patients with acute myocardial infarction and acute ischaemic stroke. J Cardiovasc Risk 1999;6:13-17.
32. Hato T, Minamoto Y, Fukuyama T, Fujita S: Polymorphism of HPA-1 through 6 on the platelet membrane glycoprotein receptors are not a genetic risk factor for myocardial infarction in the Japanese population. Am J Cardiol 1997;80:1222-1224.
33. Li YH, Chen JH, Tsai WC, Chao TH, Guo HR, Tsai LM, Wu HL, Shi GY: Synergistic effect of thrombomodulin promoter -33G/A polymorphism and smoking on the onset of acute myocardial infarction. Thromb Haemost 2002;87:86-91.
34. Voetsch B, Damasceno BP, Camargo EC, Massaro A, Bacheschi LA, Scaff M, Annichino-Bizzacchi JM, Arruda VR: Inherited thrombophilia as a risk factor for the development of ischemic stroke in young adults. Thromb Haemost 2000;83:229-233.
35. Araujo F, Santos A, Araujo V, Henriques I, Monteiro F, Meireles E, Moreira I, David D, Maciel MJ, Cunha-Ribeiro LM: Genetic risk factors in acute coronary disease. Haemostasis 1999;29:212-218.
36. Charakida M, Tousoulis D, Stefanadis C, Toutouzas P: The impact of platelet glycoprotein IIIa and Ia polymorphisms in cardiovascular thrombotic disease. Ital Heart J 2003;4:17-22.
37. 1 might be a genetic risk factor for the development of stroke in younger patients. Blood 1999;93:3583-3586.
38. Corral J, Rivera J, González-Conejero R, Vicente V: The number of platelet glycoprotein Ia molecules is associated with the genetically linked 807 C/T and HPA-5 polymorphisms. Transfusion 1999;39:372-378.